Woon Hean Chong

Dr. Woon Hean Chong

orcid

Research Focus & Metrics

Academic Career Length

37Years (1990-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
11 March 2021 in Infection
Verified
Journal Article
Closed access
PDF file
WCWoon Hean Chong
Woon Hean Chong
BSBiplab K. Saha
Biplab K. Saha
ARAnanthakrishnan Ramani
Ananthakrishnan Ramani
ACAmit Chopra
Amit Chopra

1 July 2021 in Journal of Hospital Infection
Verified
Journal Article
Closed access
WCWoon Hean Chong
Woon Hean Chong
KNK.P. Neu
K.P. Neu

1 September 2021 in Heart & Lung
Verified
Journal Article
Closed access
WCWoon Hean Chong
Woon Hean Chong
BSBiplab K. Saha
Biplab K. Saha
KHKurt Hu
Kurt Hu
ACAmit Chopra
Amit Chopra

27 September 2021 in Infection
Verified
Journal Article
Open access
PDF file
WCWoon Hean Chong
Woon Hean Chong
BSBiplab K. Saha
Biplab K. Saha
KNKristoffer P. Neu
Kristoffer P. Neu
Purpose Invasive pulmonary aspergillosis has been increasingly recognized in COVID-19 patients, termed COVID-19-associate pulmonary aspergillosis (CAPA). Our meta-analysis aims to assess the clinical characteristics and outcomes of patients diagnosed with CAPA compared to those without CAPA. Methods We searched the Pubmed, Cochrane Library, SCOPUS, and Web of Science databases for studies published between January 1, 2020 and August 1, 2021, containing comparative data of patients diagnosed with CAPA and those without CAPA. Results Eight cohort studies involving 729 critically ill COVID-19 patients with comparative data were included. CAPA patients were older (mean age 66.58 vs. 59.25 years; P = 0.007) and had underlying chronic obstructive pulmonary disease (COPD) (13.7 vs. 6.1%; OR 2.75; P = 0.05). No differences in gender, body mass index (BMI), and comorbidities of diabetes and cancer were observed. CAPA patients were more likely to receive long-term corticosteroid treatment (15.0 vs. 5.3%; OR 3.53; P = 0.03). CAPA patients had greater severity of illness based on sequential organ failure assessment (SOFA) score with a higher all-cause in-hospital mortality rate (42.6 vs. 26.5%; OR 3.39; P < 0.001) and earlier ICU admission from illness onset (mean 11.00 vs. 12.00 days; P = 0.003). ICU length of stay (LOS), invasive mechanical ventilation (IMV) duration, the requirement of inotropic support and renal replacement therapy were comparable between the two groups. Conclusions CAPA patients are typically older with underlying COPD and received long-term corticosteroid treatment. Furthermore, CAPA is associated with higher SOFA scores, mortality, and earlier onset of ICU admission from illness onset.

1 August 2021 in Respiratory Medicine
Verified
Journal Article
Closed access
ACAmit Chopra
Amit Chopra
AAAli Hani Al-Tarbsheh
Ali Hani Al-Tarbsheh
NSNidhi J. Shah
Nidhi J. Shah
HYHamid Yaqoob
Hamid Yaqoob
KHKurt Hu
Kurt Hu
Marc JudsonMarc Judson
Marc Judson

1 July 2021 in Heart & Lung
Verified
Journal Article
Closed access
WCWoon Hean Chong
Woon Hean Chong
BSBiplab K. Saha
Biplab K. Saha
ECEdward Conuel
Edward Conuel
ACAmit Chopra
Amit Chopra